VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES

The present invention provides antibody-payload conjugates having a payload-to-antibody ratio of 1. The antibody-payload conjugate having structure (1): wherein:a, b and c are each independently 0 or 1;L1, L2 and L3 are linkers;D is a payload;BM is a branching moiety;Z are connecting groups obtainable by a cycloaddition reaction.The invention further provides a method for preparing the antibody-payload conjugate according to the invention, an intermediate compound in that preparation method, and medical uses of the antibody-payload conjugate according to the invention..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 16. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

VAN DELFT FLORIS LOUIS [VerfasserIn]
HOOGENBOOM JORIN [VerfasserIn]
POPAL SORRAYA [VerfasserIn]
VAN SCHAIK ARNOLDUS JACOBUS [VerfasserIn]
DE BEVER LAUREEN [VerfasserIn]
VAN GEEL REMON [VerfasserIn]
WIJDEVEN MARIA ANTONIA [VerfasserIn]
VAN BERKEL SANDER SEBASTIAAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-16, Last update posted on www.tib.eu: 2023-12-07, Last updated: 2023-12-15

Patentnummer:

US2023364262

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018607012